
|Videos|March 28, 2016
Guidelines Pharmacists Should Refer to When Selecting a Novel Oral Anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First Oral GLP-1 for Weight Management
2
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
3
Achieving Optimal LDL-C Helps Prevent Neoatherosclerosis, Late Stent Failure in Patients With STEMI
4
High-Fiber Diet May Delay Progression of Multiple Myeloma in Patients With MGUS, SMM
5







































































































































































































